RxDoctor Payments Data

Steven Fincher

Internal Medicine · Searcy, ARNPI 1689637860

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 189 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 17 manufacturers reported payments, led by Amgen at 25.7% of the total. Reporting peaked in 2019 at $1,014 and has fallen 98.6% since, to $14 in 2024.

$2,843in general payments, 2019–2025

Across 189 payments — averaging $15.04 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Amgen$730
  • Novo Nordisk$536
  • Sanofi-aventis U.S. LLC$479
  • Pfizer$337
  • GSK$162
  • AstraZeneca$154
  • plus $445 from 11 others

What the payments were for

  • Food & beverage$2,843100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,843 in reported general payments places this provider in the 85th percentile of 614 internal medicine providers in Arkansas.

See all internal medicine providers in Arkansas →

Other internal medicine in Searcy

See the full list for Arkansas →

Where these figures come from

Is this you, or does something look wrong? →